Company: GANX
Filing Date: 2025-11-12
Form Type: 8-K
Source: 0001104659-25-110343
Chunk: 1

Company: Gain Therapeutics, Inc.
Filing Date: 2025-11-12
Form: 8-K
Item: Item 9.01
Chunk 1
---
Item 9.01. Financial Statements and Exhibits.

(d) Exhibits

The exhibits listed below are furnished as part of this Current Report on Form 8-K.

  Exhibit No.      Description                                                                   
         99.1      Gain Therapeutics, Inc. Press Release dated November 12, 2025                 
 ─────────────────────────────────────────────────────────────────────────────────────────────────
          104      Cover Page Interactive Data File (embedded within the Inline XBRL document).  

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

                               GAIN THERAPEUTICS, INC.                                                  
  Date: November 12, 2025      By:                          /s/ Gene Mack                               
                               Name:                                           Gene Mack                
                               Title:                                          Chief Executive Officer